Featured

Now Available - Three Learning Pathways from Heart Rhythm 2017
with Complimentary CME/MOC for Members

Click on the links below to learn more
 

Optimizing CRT and New Advances

This series of 18 CRT lectures is presented by international experts offering their opinions regarding controversial topics in CRT with the intent to provide a review of the literature as well as helpful guidance for specific challenging clinical scenarios.

Access Activity

 

2017 Summits Enduring Products (with CME/MOC)

Click on the links below to learn more

Optimizing CRT and New Advances

  • Description
  • Program
  • Faculty

Cardiac resynchronization therapy (CRT) is more than merely biventricular pacing in patients with ventricular conduction delay and systolic heart failure.  With the introduction of new lead technology and pacing algorithms, prescribing CRT becomes more complex.  Ultimately, the goal is a patient-specific biventricular pacing regimen that optimizes response and clinical care. 

This series of CRT lectures is presented by international experts offering their opinions regarding controversial topics in CRT with the intent to provide a review of the literature as well as helpful guidance for specific challenging clinical scenarios.

HRS Members - Complimentary (after log in)

Non-Members - $29 USD

Learning Pathway presentations* include:

  • Resynchronization Therapy Controversies - Permanent Pacing for Severe Conduction Tissue Disease in Patients with Mild LV Dysfunction: To Resynchronize or Not? – duration total <18 minutes
  • Revisiting CRT in mild heart failure: Long-term outcomes mandate a more aggressive approach–duration < 19 minutes
  • Permanent Pacing in a Patient with High Degree AV Block and Preserved Ejection Fraction: Is CRT the Way to Go? – duration <18 minutes
  • Debate - His Bundle Pacing After AVJ Ablation – duration <45 minutes
  • It's Not All About the Lead: Integrating Programming and New Device Technology – duration <98 minutes
    • The Role of LV-Only Pacing in Improving CRT Outcome – duration <25 minutes
    • Rationale and Methods for Achieving AV and VV Optimization – duration <22 minutes
    • Multisite Pacing Do's & Don’ts – duration <27 minutes
    • Optimal Programming for Shock Reduction in CRT Patients – duration <24 minutes
  • Echocardiography Vs Non-invasive Hemodynamic Optimization of AV and VV delay for Cardiac Resynchronization Therapy: The Prospective, multi-centre, randomized, cross-over, non-inferiority BRAVO study.British Randomized Controlled Trial of AV and VV Optimization ("BRAVO") study – duration <20 minutes
  • Impact of Remote Monitoring on Outcome and Survival in CRT Patients – duration <24 minutes
  • Future Directions in CRT: The Impact of Pacing Site on Outcome – duration <20 minutes
  • Infective Complications of CRT in Responder and Superresponder - Periprocedural Management – duration <25 minutes
  • CRT: Emerging Methods and Technology – duration <34 minutes
    • Wireless LV Endocardial Stimulation for Cardiac Resynchronization: Long-term (12 month) Experience of Clinical Efficacy and Clinical Events from Two Centers – duration <16 minutes
    • Leadless LV endocardial stimulation for CRT: Final Outcomes of the Safety and Performance of Electrodes implanted in the Left Ventricle (SELECT-LV) Study – duration <18 minutes
  • How the Minimally Invasive Surgical Approach Can Get the LV Lead in the Best Location – duration <18 minutes
  • Cardiac Resynchronization Therapy in Patients with Fontan Physiology and Heart Block – duration <13 minutes

*Paticipation only / continuing education credits/points NOT available for this activity

Faculty -
Maurizio Gasparini, MD
Rozzano-Milano
Italy

Anthony S. Tang, MD, FHRS
London, Ontario
Canada

Anne Curtis, MD, FHRS
Buffalo, New York

Kenneth A. Ellenbogen, MD, FHRS
Richmond, Virginia

Jeanne E. Poole, MD, FHRS, CCDS
Seattle, Washington

Marye Gleva, FHRS
St. Louis, Missouri

Christophe Leclercq, MD
Rennes, France

Laurence D. Sterns, MD, FHRS
Victoria, British Columbia,
Canada

Zachary I Whinnett, BMBS, PhD
Rickmansworth, United Kingdom

Niraj Varma, MD, PhD
Cleveland, Ohio

Gery Tomassoni, MD, FHRS
Lexington, Kentucky

Bruce L. Wilkoff, MD, FHRS, CCDS
Cleveland, Ohio

Petr Neuzil, MD, PhD
Prague, Czech Republic

Vivek Y. Reddy, MD
New York, New York

Jamil Bashir, MD
Vancouver, British Columbia Canada

Edward O'Leary, MD
Boston, Massachusetts

Global Rhythm Exchange - Highlights From The 12th International Symposium on Ventricular Arrhythmias: Pathophysiology & Therapy

  • Highlights - In case you missed it
  • View Select Sessions NOW!
  • Full Program Schedule

The 12th International Symposium on Ventricular Arrhythmias: Pathophysiology & Therapy is hosted by the Department of Medicine, Division of Cardiology,University of Pennsylvania Health System, Philadelphia, PA and the Division of Cardiology, The Mount Sinai Hospital, New York, NY.

View select highlights from the October 13 - 14, 2017 conference - 

 

Program Objectives

Provide a review of new information on the basic pathophysiology of ventricular arrhythmias.

Provide an in-depth understanding of current management strategies used for the care of ventricular arrhythmias in various disease states, including non-pharmacological therapies such as implantable device and catheter ablation techniques.

His Bundle Pacing for Cardiomyopathy Patients: An Alternative to CRT?  (duration <12 minutes)
Kenneth Ellenbogen, MD

Complete Epi-Endo Circuit Delineation of Human VT  (duration <14 minutes)
Roderick Tung, MD

Management of Anticoagulation Issues and Bleeding  (duration <11 minutes)
William G. Stevenson, MD

Flecainide Therapy for PVC-Related Cardiomyopathy  (duration <9 minutes)
David Frankel, MD

Imaging for Risk Stratification for Mild-Moderate LV Dysfunction in NICM  (duration <12 minutes)
Sanjay Prasad, MD

Does ARVC Always Progress? Adverse Remodeling versus More Scar  (duration <13 minutes)
Francis Marchlinski, MD

New Insights from the Hopkins ARVC Registry  (duration <12 minutes)
Hugh Calkins, MD

Anatomy/Ablation of LV Summit VT  (duration <12 minutes)
Samuel Asirvatham, MD

To view full session content, please visit the 12th International Symposium website.

Journal CME/HeartRhythm Journal: February 2018 Class 1C antiarrhythmic drugs for suspected premature ventricular contraction-induced cardiomyopathy

  • Description
  • Faculty
  • CME Information

Class 1C anti-arrhythmic drugs (1C-AAD) can effectively suppress premature ventricular contractions (PVC). However, 1C-AADs increase mortality in patients with PVCs and left ventricular (LV) dysfunction following myocardial infarction. Whether 1C-AADs can be safely used to treat PVC-induced cardiomyopathy (PVC-CM) remains to be established. The objective of this article is to determine the safety and efficacy of 1C-AADs in patients suspected of having PVC-CM.

Matthew C. Hyman, MD, PhD
Danielle Mustin, BS
Gregory Supple, MD
Robert D. Schaller, DO
Pasquale Santangeli, MD, PhD
Jeffrey Arkles, MD
David Lin, MD, FHRS
Daniele Muser, MD
Sanjay Dixit, MD, FHRS
Saman Nazarian, MD, PhD
Andrew E. Epstein, MD, FHRS
David J. Callans, MD, FHRS
Francis E. Marchlinski, MD, FHRS
David S. Frankel, MD, FHRS

Accreditation

The Heart Rhythm Society designates this journal-based CME activity for a maximum of AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  The method of participation is online/electronic only.

The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical  Education (ACCME) to provide continuing medical education for physicians.

CIED Learning Pathway - Heart Rhythm 2017

  • Description
  • Learning Objectives
  • Presentations / Faculty

The CIED Learning Pathway contains presentations from Heart Rhythm 2017, held on May 10 - 13 in Chicago, IL

Nonpharmacologic therapies for management of arrhythmias is expanding beyond merely pacemakers and defibrillators.  Advances in device technology now provide a host of features to assist with monitoring for disease, such as acute heart failure as well as occurrence of atrial arrhythmias even when asymptomatic.  These advances are especially impactful with remote monitoring, which provides prompt response to device-stored data. The future of implanted devices will likely be focused on monitoring physiologic parameters with the intent of early intervention to avert decompensation or adverse sequelae.

Earn up to 4.5 CME credits and 4.5 MOC points*

(*Each presentation is up to 0.5 CME credits/MOC points)

List Price

$125

Member

Complimentary

Non-Member

$125

Learning Objectives

Upon completion of this educational activity, participants will be able to:

1. To identify ICD indications for ischemic/nonischemic caridomyopathies and genetic heart disease
2. To understand how to optimize utilization of implantable loop recorders
3. To recognize varied techniques to enhance pacing therapy in patients with heart failure
4. Use of hemodynamic monitors in patients with conduction disease

The CIED Learning Pathway contains the following presentations from Heart Rhythm 2017:

How Do You Choose Which Implantable Loop Recorder to Whom?
Faculty - Sze-Yuan Michael Ooi, MBBS

How to program ILRs for different clinical conditions - improving yield! 
Faculty - Mevan N. Wijetunga, MD, FHRS

Patients with Reduced Left Ventricular Systolic Function 
Faculty - Sana M. Al-Khatib, MD, MHS, FHRS, CCDS

Patients with Non-ischemic and Infiltrative Cardiomyopathies
Faculty - Suraj Kapa, MD, FHRS

ICD in Patients with Genetic Heart Diseases
Faculty - Wojciech Zareba, MD, PhD

Dual Chamber Pacing: Understanding Ventricular Pacing Avoidance Algorithms
Faculty - Abhishek J. Deshmukh, MD

Is LV Only Pacing as Good as BIV Pacing? 
Faculty - Christophe Leclercq, MD, PhD

How to Optimize His Bundle Capture 
Faculty - Gopi Dandamudi, MD, FHRS

Pulmonary Arterial Pressure Monitors - Post Market Data
Faculty - William T. Abraham, MD

Journal CME/HeartRhythm Journal: January 2018, Vol. 15, Issue 1: Clinical effectiveness of a systematic "pill-in-the-pocket" approach for the management of paroxysmal atrial fibrillation

  • Description
  • Faculty
  • CME Information

For patients with symptomatic, sustained atrial fibrillation (AF), a “pill-in-the-pocket” antiarrhythmic drug (PIP-AAD) strategy has been proposed to reduce emergency department (ED) use. The objective of this article is to assess the clinical utility of a protocolled PIP-AAD approach within contemporary practice.

Jason G. Andrade, MD
Jenny MacGillivray, BScPharm
Laurent Macle, MD
Ren Jie Robert Yao, BSc
Matthew Bennett, MD
Christopher B. Fordyce, MD, MHS, MSc
Nathaniel Hawkins, MD
Andrew Krahn, MD
John Jue, MD
Krishnan Ramanathan, MD
Teresa Tsang, MD
Ken Gin, MD
Marc W. Deyell, MD, MS

Accreditation

The Heart Rhythm Society designates this journal-based CME activity for a maximum of AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  The method of participation is online/electronic only.

The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical  Education (ACCME) to provide continuing medical education for physicians.

Clinical EP Learning Pathway - Heart Rhythm 2017

  • Description
  • Learning Objectives
  • Presentations / Faculty

The Clinical EP Learning Pathway is a collection of presentations from Heart Rhythm 2017 held May 10 - 13 in Chicago, IL.   This  pathway explores the role of anatomic variations for left atrial appendage closure and health economics of this procedure, the optimal management of patients with heart failure and atrial fibrillation, ECG clues to help with arrhythmia diagnosis and the management of arrhythmias in heart failure and uncommon cardiomyopathies.

Earn up to 5.5 CME credits and 5.5 MOC points*

(*Each presentation is up to 0.5 CME credits/MOC points)

List Price

$125

Member

Complimentary

Non-Member

$125

Learning Objectives

Upon completion of this educational activity, participants will be able to:

1. Assess the role of anatomic variations in LAA Closure and the impact of this procedure on health economics.
2. Impact and management of atrial fibrillation in patients with heart failure.
3. Use ECG clues to decipher arrhythmia origin and mechanism
4. Management of ventricular arrhythmias in end stage heart failure
5. Identify strategies for arrhythmia management in cardiomyopathies including infiltrative,Takotsubo cardiomyopathies and acute myocarditis

Clinical EP Learning Pathway include the following presentations from Heart Rhythm 2017:

From P Wave Morphology to the Site of Origin and Mechanism of SVT 
Faculty - Teiichi Yamane, MD, PhD, FHRS

12 Lead (Holter) ECG in “Polymorphic” VPC: Sort Out the Chaos Before You Treat It 
Faculty - Helmut Puererfellner, MD

How LAA Anatomical Variants Influence Procedure Success and Closure Device Selection 
Faculty - Vivek Y. Reddy, MD

Is LAA Closure a Cost Effective Alternative to Oral Anticoagulation?
Faculty - Mintu P. Turakhia, MD, MS

Atrial Fibrillation and Heart Failure: A Review of Studies Prior to 2016
Faculty - Albert L. Waldo, MD, FHRS, CCDS

Is There Still a Role for Anti-Arrhythmic Therapy in AF Patients with Heart Failure?
Faculty – Isabelle C. Van Gelder, MD, PhD

Stress Cardiomyopathy 
Faculty - Ilan S. Wittstein, MD

Acute Myocarditis 
Faculty - Jeffrey A. Towbin, MD

Infiltrative Cardiomyopathies 
Faculty - Christopher J. McLeod, MD, PhD, FHRS

Managing Ventricular Arrhythmias in End Stage Heart Failure: Pharmacologic Considerations 
Faculty - Ratika Parkash, MD, MS, FHRS

Managing Ventricular Arrhythmias in Patients with End Stage Heart Failure: The Role of Catheter Ablation
Faculty - Frederic Sacher, MD, PhD

Catheter Ablation Learning Pathway - Heart Rhythm 2017

  • Description
  • Learning Objectives
  • Presentations/Faculty

Catheter Ablation Learning Pathway is comprised of presentations from Heart Rhythm 2017, held May 10 - 13 in Chicago, IL.

This activity delivers discussion of cutting-edge ablation strategies from professionals well versed in ablation guidelines, strategies and  techniques.  World experts In the field share their tips and tricks for complex anatomy, troubleshooting both the routing and rare cases.  Atrial fibrillation, accessory pathways, ventricular tachycardia and sudden death are all addressed in concise, bite-sized sessions packed with knowledge.

Earn up to 3.5 CME credits and 3.5 MOC points*

(*Each presentation is 0.5 CME Credits/MOC Points)

List Price

$125

Member

Complimentary

Non-Member

$125

Upon completion of this educational activity, participants will be able to:

1. To discuss effective mapping and ablation strategies to ablate Long RP Tachycardias and unusual accessory pathways
2. To review the evidence for the benefits of catheter ablation and risk factor modification for atrial fibrillation patients
3. To Explain How Imaging Tools can help aid in planning ablation in complex VT cases

Catheter Ablation Learning Pathway include the following presentations from Heart Rhythm 2017:

What is the Optimal Approach to Procedural Anticoagulation in 2017?
Faculty - Jasbir S. Sra, MD, FHRS

Risk Factor Modification for AF Ablation Patients: What is the Evidence in 2017?
Faculty - Dennis H. Lau, MD, FHRS, CCDS

Evidence for Stroke Prevention
Faculty - Ross Hunter, PhD, FESC

Evidence for Mortality Benefit
Faculty - Nassir F. Marrouche, MD, FHRS

How I Approach the Long RP Tachycardia
Faculty - Melvin Scheinman, MD, FHRS

Use Parahisian Pacing and Differential Pacing to Guide Ablation
Faculty - Mario Gonzalez, MD, FHRS

Tailoring the Intervention to Disease-Specific Arrhythmia Substrate: How Can Pre-Procedural Imaging Help Inform an Interventional Strategy for Ventricular Tachycardia?
Faculty - Antonio Berruezo, MD, PhD

Journal CME/HeartRhythm Journal: December 2017 Vol. 14, Issue 12: When and how to target atrial fibrillation sources outside the pulmonary veins: A practical approach

  • Description
  • Faculty
  • CME Information

The overall goal of this activity is to reinforce the importance of non-pulmonary vein (PV) targets in patients with persistent atrial fibrillation. By identifying these targets, we will be able to improve outcomes of patients who do not readily respond to simple PV isolation. 

Aman Chugh, MD, FHRS

Accreditation

The Heart Rhythm Society designates this journal-based CME activity for a maximum of AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.  The method of participation is online/electronic only.

The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical  Education (ACCME) to provide continuing medical education for physicians.

2017 Remote Monitoring Update Webinar

  • Description
  • Learning Objectives and Faculty
  • CME Information

Remote Monitoring Update 

This 3-part series will highlight recommendations outlined in the 2015 HRS consensus statement:  Remote Monitoring Interrogation and Monitoring for Cardiovascular Implantable Electronic Devices and provide an update on clinical comparative effectiveness studies published since 2015 for remote monitoring.

 

Support

This enduring material is supported in part by Biotronik, Inc.

Learning Objectives

  • Discuss the outcomes of new clinical studies for remote monitoring of patients with cardiovascular implantable electronic devices.
  • Develop a strategy for implementing remote CIED monitoring and interrogation, including patient education.
  • Identify when to offer remote monitoring as an option to CIED patients.
  • Recognize when to refer patients to an appropriate center that provides remote monitoring.

Faculty

Niraj Varma, MD, PhD
Cleveland Clinic
Cleveland, OH

Kenneth A. Ellenbogen, MD, FHRS
Medical College of Virginia
Richmond, VA

Suneet Mittal, MD, FHRS
The Valley Health System of New York and New Jersey
New York, NY

CME Information

ACCREDITATION STATEMENT
The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA CREDIT DESIGNATION STATEMENT
The Heart Rhythm Society designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The AMA has determined that physicians not licensed in the United States who participate in this CME activity are eligible for AMA PRA Category 1 Credit™.

A Certificate of Participation (for non-physicians) will be provided to individuals seeking credit from the following organizations which accept AMA PRA Category 1 Credit(s)™. Note that participants are advised to contact their certifying body for specific information regarding credit submissions:

  • American Academy of Family Practice (AAFP) for elective credit
  • American Academy of Nurse Practitioners Certification Board (AANPCB)
  • American Academy of Physician Assistants (AAPA)
  • American Nurses Credentialing Center (ANCC)
  • American Osteopathic Association (AOA) for Category 2 credit
  • European Board of Accreditation in Cardiology (EBAC)
  • European CME Credits (ECMEC)

Real World Experience with the Subcutaneous ICD in the United States: The S-ICD Post-Market Approval Study

  • Description
  • Faculty
  • Support

The subcutaneous ICD (S-ICD) was developed to reduce short and long term complications associated with transvenous ICD leads. Early studies in the US and Europe were enriched with younger patients with less left ventricular systolic dysfunction and fewer comorbidities than transvenous ICD subjects, making comparisons between systems difficult. Following FDA approval in 2012 a prospective registry of the S-ICD was undertaken, which is the largest study of this device to date. 

Pre-implantation patients were enrolled if they met criteria for ICD, passed at least one vector in ECG screening and had a life expectancy > 1 year. Implant technique, programming and conversion testing were performed using the standard of care of investigational centers. Results were analyzed with descriptive statistics, Kaplan Meier time to event analysis, and multivariate logistic regression.

Following FDA approval of the S-ICD, a prospective study was initiated.  The cohort and short term results will be presented.

Michael R. Gold, MD, PHD, FHRS
Medical University of South Carolina
Charleston, SC

As Presented at Heart Rhythm 2017:
Late-Breaking Clinical Trials Session
C-LBCT01. Late-Breaking Clinical Trials I
Thursday, May 11, 2017

This enduring product supported in part by Boston Scientific Corporation.

Heart Rhythm On Demand 2017

  • Description
  • Pricing
  • Heart Rhythm 2017 Program Format

Heart Rhythm On Demand 2017*
The Heart Rhythm On Demand product is comprised of the sessions and presentations from Heart Rhythm 2017. 

The focus of Heart Rhythm 2017 showcases the ideas, people, and technology that continue to propel our field forward with sessions that represented all aspects of pacing, defibrillation, clinical arrhythmia management, ablation, pharmacology, genetics, basic science, and health policy.

*Continuing Education credits are NOT available for this content

List Price = $1,295

HRS Member = $725

Non-Member = $975

HRS Member Allied/Fellows In Training = $425

*Non-Member Allied/Fellows In Training = *$525

USB Add-on  = $125

(**only available as an add-on to the purchase of online product)

 

 

 

 

 

 

 

*If you are a Non-Member Allied Professional / Fellow In Training, please Contact Usfor special pricing.

Please include your title, facility name and complete contact information.

Heart Rhythm Sessions on Demand includes hours of education broken into the following tracks:

  • Allied Professionals
  • Basic/Translational Science
  • Cardiovascular Implantable Electronic Devices and Heart Failure
  • Clinical EP and Catheter Ablation
  • Pediatric/Adult Congenital Heart Disease

NOTE - Continuing Education credits are NOT available for this content

 

Summits On Demand 2017

  • AF Summit
  • VT/VF Summit
  • Lead and Device Management Summit

AF Summit provides a comprehensive review AF ablation and evolving therapies that are changing the field. Session topics include the role of the autonomic nervous system in cause and management of AF, the ongoing challenge of longstanding persistent AF, and new technologies for AF ablation. Attendees will leave this session with advanced knowledge of this rapidly evolving field. 

 Access for Summit Attendees ONLY

VT/VF Summit provides a state-of-the-art discussion regarding all aspects of managing patients with ventricular arrhythmias.  Ablation of idiopathic VT in unusual anatomic locations, ablation of VT in structural heart disease, and an overview of the current knowledge regarding the sudden cardiac death syndrome will be discussed by experts in this field.

Access for Summit Attendees ONLY

Lead and Device Management Summit - the Lead & Device Management Summit will focus on present and future treatments of issues as well as the pros and cons of new treatment modalities.

 Access for Summit Attendees ONLY

EP Ablation Technologies

  • Description
  • Program
  • Faculty

The activity below contains a number of presentations by world experts describing the status of different novel ablation technologies. These include a wide selection of tools ranging from the recently developed contact force sensing, and rotor mapping and ablation, to novel and futuristic ablation technologies such as extra-corporeal non-invasive ablation using Carbon ion particle therapy. The information presented provide the reader with an up-to-date summary of these technologies and a preview on how the field will look like in next 5-10 years.

HRS Members - Complimentary (after log in)

Non-Members - $29 USD

Learning Pathway presentations* include:

  • Biophysics for Electrophysiologists – duration total <84 minutes
  • Contact Force Sensing During AF Ablation - Technologies, Results and Impact on Clinical Outcomes –duration < 18 minutes
  • EP on Point:  Cryoballoon vs. RF Ablation for PVI – duration <22 minutes
  • AF Ablation Tools – duration <30 minutes
  • Debate - Paroxysmal AF Ablation: Use the Force or Ice it! – duration <45 minutes
  • Debate-Cryo vs. Fry-o – duration <45 minutes
  • New Tools and Approaches for AF Management – duration <50 minutes

*Paticipation only / continuing education credits/points NOT available for this activity

David E. Haines, MD, FHRS 
Beaumont Health
Royal Oak, MI 

Gregory F. Michaud, MD, FHRS
Brigham and Women's Hospital
Boston, MA

Andre d'Avila, MD, PhD
Hospital Cardiologico
Florianopolis, Brazil

Boaz Avitall, MD, PhD, FHRS
University of Illinois
Chicago, IL

Moussa Mansour, MD
Massachusetts General Hospital
Institute for Heart, Vascular and Stroke Care
Boston, MA

Jason Andrade BSc, FRCPC
Vancouver General Hospital and University of British Columbia
Montreal Heart Institute and Université de Montreal

Karl-Heinz Kuck, MD, FHRS
Asklepios Klinik St. Georg
Hamburg, Germany

Ellen Hoffmann, MD
Heart Center Munich-Bogenhausen
Munich, Germany

Roland R. Tilz, MD
Asklepios Klinik St. Georg 
Hamburg, Germany

Richard J. Czosek, MD, CCDS
Cincinnati Children's Hospital
Cincinnati, OH

Peter S. Fischbach, MD, MA, CCDS
Sibley Heart Center
Atlanta, GA

Petr Neuzil, MD, PhD
Na Homolce Hospital
Prague, Czech Republic

Isabel V. Deisenhofer, MD
Deutsches Herzzentrum München
Munich, Germany

Douglas Packer, MD, FHRS 
Mayo Clinic
Rochester, MN

The MACRA Final Rule: A 2017 Primer for Electrophysiologists

  • Description
  • Learning Objectives
  • Faculty

This forty minute complimentary on-demand webinar, presented by Michael Gold, MD, FHRS and Robert Jasak, JD, will provide an overview of the new program as it is detailed in the final rule. If you have questions while you watch the webinar, you can emailyour questions to HRS at policy@hrsonline.org.

  • Understand the MACRA framework
  • Explain the differences between the Medicare fee-for-service and MACRA payment structures
  • Discuss MACRA’s implications for heart rhythm professionals
Faculty

Michael R. Gold, MD, PhD, FHRS
President, Heart Rhythm Society

Robert Jasak, JD
Vice-President
Coverage and Payment Policy
Hart Health Strategies, Inc.

View All Activities